Part of The Raymond G. Perelman Center for Cellular and Molecular Therapeutics, the Research Vector Core is designed and developed to support investigators interested in using viral vectors in their research model systems.
The research vector core (RVC) utilizes well-established techniques to engineer and produce recombinant AAV and lenti viral vectors for gene transfer in in vitro/in vivo experiments or non-clinical studies. RVC staff work closely with investigators to plan and develop vectors for individual project requirements. The RVC has extensive experience in the production of multiple AAV serotypes and Lenti vector. Due to its unique manufacturing method, resulting in high productivity, the RVC is able to deliver empty capsid free (<1%)AAV vectors after the purification process. Reporter gene vectors are available directly from inventory.